VALIANTLAB

Valiant Laboratories Share Price

₹100.59 +4.19 (4.35%)

04 May, 2025 12:43

SIP TrendupStart SIP in VALIANTLAB

Start SIP

Performance

  • Low
  • ₹94
  • High
  • ₹101
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹168
  • Open Price₹96
  • Previous Close₹96
  • Volume13,597

Investment Returns

  • Over 1 Month + 9.8%
  • Over 3 Month + 2.25%
  • Over 6 Month -13.61%
  • Over 1 Year -34.7%
SIP Lightning

Smart Investing Starts Here Start SIP with Valiant Laboratories for Steady Growth!

Invest Now

Valiant Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -105.5
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 437
  • P/B Ratio
  • 1.9
  • Average True Range
  • 5.84
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.27
  • RSI
  • 57.14
  • MFI
  • 68.31

Valiant Laboratories Financials

Valiant Laboratories Technicals

EMA & SMA

Current Price
₹100.59
+ 4.19 (4.35%)
pointer
  • stock-down_img
  • Bearish Moving Average 4
  • stock-up_img
  • Bullish Moving Average 12
  • 20 Day
  • ₹96.34
  • 50 Day
  • ₹94.55
  • 100 Day
  • ₹99.20
  • 200 Day
  • ₹111.92

Resistance and Support

98.6 Pivot Speed
  • R3 110.44
  • R2 105.83
  • R1 103.21
  • S1 95.98
  • S2 91.37
  • S3 88.75

What's your outlook on Valiant Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Valiant Laboratories Ltd has an operating revenue of Rs. 106.18 Cr. on a trailing 12-month basis. An annual revenue de-growth of -43% needs improvement, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 7% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 31 which is a POOR score indicating inconsistency in earnings, a RS Rating of 29 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 20 indicates it belongs to a strong industry group of Medical-Whlsle Drg/Suppl and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Valiant Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-07 Quarterly Results & Others To consider other business matters.
2024-11-12 Quarterly Results
2024-08-12 Quarterly Results
2024-05-14 Audited Results
2024-02-09 Quarterly Results

Valiant Laboratories F&O

Valiant Laboratories Shareholding Pattern

74.94%
0.64%
16.29%
8.13%

About Valiant Laboratories

  • NSE Symbol
  • VALIANTLAB
  • BSE Symbol
  • 543998
  • Managing Director
  • Mr. Santosh S Vora
  • ISIN
  • INE0JWS01017

Similar Stocks to Valiant Laboratories

Valiant Laboratories FAQs

Valiant Laboratories share price is ₹100 As on 04 May, 2025 | 12:29

The Market Cap of Valiant Laboratories is ₹437.1 Cr As on 04 May, 2025 | 12:29

The P/E ratio of Valiant Laboratories is -105.5 As on 04 May, 2025 | 12:29

The PB ratio of Valiant Laboratories is 1.9 As on 04 May, 2025 | 12:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23